论著·临床实践

血清IMA、sST2、ApoB/ApoA1与急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后心电图ST段回落不良的关系

  • 唐茜 ,
  • 刘泽岩 ,
  • 程景林
展开
  • 安徽医科大学第二附属医院急诊内科 (安徽 合肥 230000 )

收稿日期: 2025-11-28

  修回日期: 2026-01-14

  录用日期: 2026-01-16

  网络出版日期: 2026-03-26

基金资助

安徽省高校科研项目(自然科学类)计划项目(2024AH050795)

The relationship of serum IMA, sST2, ApoB/ApoA1 with poor ST segment regression on electrocardiogram after PCI in STEMI patients

  • Qian TANG ,
  • Zeyan LIU ,
  • Jinglin CHENG
Expand
  • Emergency Internal Medicine,the Second Affiliated Hospital of Anhui Medical University,Hefei 230000,Anhui,China

Received date: 2025-11-28

  Revised date: 2026-01-14

  Accepted date: 2026-01-16

  Online published: 2026-03-26

摘要

目的 探析血清缺血修饰蛋白(ischemia-modified albumin, IMA)、可溶性生长刺激表达基因2蛋白(soluble growth stimulation expressed gene 2 protein,sST2)、载脂蛋白B(apolipoprotein B,ApoB)/载脂蛋白A1(apolipoprotein A1,ApoA1)与急性ST段抬高型心肌梗死(acute ST-segment elevation myocardial infarction,STEMI)患者经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后心电图ST段回落不良的关系。 方法 选取安徽医科大学第二附属医院2022年9月至2025年9月急诊内科收治行急诊PCI治疗的102例STEMI患者,按术后心电图ST段回落率分为回落不良组(ST段回落率< 50%,n = 31)与回落良好组(ST段回落率≥ 50%,n = 71),比较两组PCI术前、术后24 h血清IMA、sST2、ApoB/ApoA1水平,并收集两组人口学资料、病史资料、PCI治疗相关资料等,筛选STEMI术后ST段回落不良的影响因素,分析术前血清IMA、sST2、ApoB/ApoA1预测ST段回落不良的价值。 结果 102例患者术后2 h心电图示回落不良31例(30.39%),回落良好71例(69.61%),回落不良组发病至入院时间>6 h占比、冠脉左前降支梗死占比、Killip分级≥Ⅱ级占比高于回落良好组,TIMI血流Ⅲ级占比低于回落良好组(P < 0.05);较同组术前,术后24 h两组血清IMA、sST2、ApoB/ApoA1均降低(P < 0.05),回落不良组术前、术后24 h血清IMA、sST2、ApoB/ApoA1均高于回落良好组(P < 0.05);术前血清IMA预测STEMI患者PCI术后ST段回落不良的曲线下面积、敏感度、特异度分别为0.818、80.65%、73.24%;sST2为0.778、64.52%、95.77%;ApoB/ApoA1为0.866、70.98%、90.14%;联合预测为0.931、77.42%、98.59%,其中联合预测效能最高(P < 0.05);冠脉左前降支梗死(OR = 2.962、术前IMA(OR = 2.354)、术前sST2(OR = 2.517)、术前ApoB/ApoA1(OR = 2.863)是影响STEMI患者PCI术后ST段回落的危险因素(P < 0.05);构建多因素logistic回归模型,logit(P) = -2.568 + 0.245 × 发病至入院时间(h) + 1.086 × 冠脉左前降支梗死 + 0.702 × Killip分级 + 0.935 × TIMI血流分级 + 0.856 × 术前IMA + 0.923 × 术前sST2 + 1.052 × 术前ApoB/ApoA1,该模型预测STEMI患者PCI术后ST段回落不良的发生的曲线下面积为0.956(95%CI:0.897 ~ 0.987),敏感度87.10%,特异度92.96%,Z = 22.366,P < 0.001,模型拟合优度检验χ2=5.971,P > 0.05,模型校准度良好;DCA曲线示,阈值概率在6% ~ 92%时以模型为参考可获得较高的临床效益。 结论 冠脉左前降支梗死及术前高IMA、sST2、ApoB/ApoA1比值均与STEMI患者PCI术后ST段回落不良有关,联合模型预测ST段回落不良可行性较高。

本文引用格式

唐茜 , 刘泽岩 , 程景林 . 血清IMA、sST2、ApoB/ApoA1与急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后心电图ST段回落不良的关系[J]. 实用医学杂志, 2026 , 42(6) : 1078 -1087 . DOI: 10.3969/j.issn.1006-5725.2026.06.022

Abstract

Objective To explore the relationship between serum ischemia-modified albumin (IMA), soluble growth stimulation expressed gene 2 protein (sST2), apolipoprotein B (ApoB)/ApoA1 and poor ST segment regression in electrocardiogram after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI). Methods A total of 102 STEMI patients who received PCI treatment in the emergency department of the Second Affiliated Hospital of Anhui Medical University between September 2022 and September 2025 were selected. These patients were then divided into the poor regression group (with an ST-segment regression rate < 50%, n = 31) and the good regression group (with an ST-segment regression rate ≥50%, n = 71) based on the ST-segment regression rate of the postoperative electrocardiogram. The levels of serum IMA, sST2, and ApoB/ApoA1 were compared between the two groups before PCI and 2 hours after PCI. Demographic data, medical history data, and PCI-treatment-related data of the two groups were collected to screen for the influencing factors of poor ST-segment regression after STEMI. The predictive value of preoperative serum IMA, sST2, and ApoB/ApoA1 for poor ST-segment regression was analyzed. Results Among the 102 patients, 31 (30.39%) exhibited poor electrocardiogram regression 2 hours after the operation, and 71 (69.61%) showed good regression. The percentages of patients with a time from onset to admission > 6 hours, left anterior descending coronary artery infarction, and Killip grade ≥ Ⅱ were higher in the poor-regression group, whereas the percentage of TIMI blood flow grade 3 was lower (P < 0.05). When comparing the same group before and 2 hours after the operation, serum IMA, sST2, and ApoB/ApoA1 levels decreased in both groups (P < 0.05). The levels of serum IMA, sST2, and ApoB/ApoA1 in the poor-regression group before and 2 hours after the operation were higher (P < 0.05). The area under the curve, sensitivity, and specificity of preoperative serum IMA for predicting poor ST-segment regression in STEMI patients after PCI were 0.818, 80.65%, and 73.24%, respectively; those of sST2 were 0.778, 64.52%, and 95.77%, respectively; those of ApoB/ApoA1 were 0.866, 70.98%, and 90.14%, respectively; and those of the combined prediction were 0.931, 77.42%, and 98.59%, respectively. Among them, the combined prediction had the highest efficacy (P < 0.05). Left anterior descending coronary artery infarction (OR = 2.962), preoperative IMA (OR = 2.354), preoperative sST2 (OR = 2.517), and preoperative ApoB/ApoA1 (OR = 2.863) were risk factors influencing ST-segment regression after PCI in STEMI patients (P < 0.05). A multi-factor logistic regression model was constructed: logit(P) = -2.568 + 0.245 × Time from Onset to Admission (h)+1.086 × Infarction of the Left Anterior Descending Coronary Artery + 0.702 × Killip Classification + 0.935 × TIMI Flow Grade + 0.856 × Preoperative IMA + 0.923 × Preoperative sST2 + 1.052 × Preoperative ApoB/ApoA1. The area under the curve of this model for predicting poor ST-segment resolution after PCI in STEMI patients was 0.956 (95% CI: 0.897 - 0.987), with a sensitivity of 87.10% and a specificity of 92.96%, Z = 22.366, P < 0.001. The goodness-of-fit test of the model yielded a χ2 value of 5.971, with P > 0.05, which indicates good calibration of the model. The DCA curve showed that when the threshold probability was between 6% and 92%, using the model as a reference could achieve high clinical benefits. Conclusions Infarction of the left anterior descending coronary artery, preoperative high ratios of IMA, sST2, and ApoB/ApoA1 are all associated with poor ST-segment regression after PCI in STEMI patients. Moreover, the combined model shows relatively high feasibility in predicting the occurrence of adverse events related to ST-segment regression.

参考文献

[1] BISCAGLIA S, GUIDUCCI V, ESCANED J, et al. Complete or culprit-only PCI in older patients with myocardial infarction[J]. N Engl J Med, 2023, 389(10): 889-898. doi:10.1056/NEJMoa2300468 .
[2] WU C, GAO X, LI L, et al. Role of ST-segment resolution alone and in combination with TIMI flow after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction[J]. J Am Heart Assoc, 2023, 12(14): e029670. doi:10.1161/JAHA.123.029670 .
[3] GHAFFARI S, KOLAHDOUZAN K, RAHIMI M, et al. Predictors of ST depression resolution in STEMI patients undergoing primary PCI and its clinical significance[J]. Int J Gen Med, 2020, 13: 271-279. doi:10.2147/IJGM.S258573 .
[4] KASSAM N, VARWANI M, NGUNGA M, et al. Ten-year review of ST-Segment Elevation Myocardial Infarction (STEMI) in Tanzania: A single center retrospective review[J]. Pan Afr Med J, 2024, 49: 82. doi:10.11604/pamj.2024.49.82.45351 .
[5] CHAUDHARY A J, IQBAL S, AHMAD KHAN N, et al. Comparative effects of rosuvastatin and atorvastatin loading doses on immediate post-percutaneous coronary intervention (PCI) thrombolysis in myocardial infarction (TIMI) flow in ST-segment elevation myocardial infarction (STEMI) patients[J]. Cureus, 2024, 16(11): e74076. doi:10.7759/cureus.74076 .
[6] WANG Z, PENG J. The predictive value of the nomogram model of clinical risk factors for ischemia–reperfusion injury after primary percutaneous coronary intervention[J]. Sci Rep, 2023, 13: 5084. doi:10.1038/s41598-023-32222-2 .
[7] XIANG L, ZHANG M, WU H, et al. The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease[J]. Ann Palliat Med, 2021, 10(4): 4463-4471. doi:10.21037/apm-21-425 .
[8] ZHANG Y, ZHANG L, CHEN Z. Effect of combining sST2/HDL-C ratio with risk factors of coronary heart disease on the detection of angina pectoris in Chinese: A retrospective observational study[J]. Cardiovasc Diagn Ther, 2023, 13(2): 345-354. doi:10.21037/cdt-22-520 .
[9] CHE W, JIN Y, CHANG S, et al. Prediction of myocardial ischemia-reperfusion injury post-PCI: Role of sST2 levels in STEMI patients[J]. BMC Cardiovasc Disord, 2025, 25(1): 280. doi:10.1186/s12872-025-04708-6 .
[10] ZHOU Y, LIU H, YANG H, et al. The value of the apolipoprotein B/apolipoprotein A1 ratio in predicting the rapid progression of non-culprit coronary lesions in acute coronary syndrome in patients with diabetes mellitus after percutaneous coronary intervention[J]. Int Heart J, 2023, 64(4): 562-569. doi:10.1536/ihj.22-676 .
[11] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-783. doi:10.3760/cma.j.issn.0253-3758.2019.10.003
[11] doi:10.3760/cma.j.issn.0253?3758.2019.10.003. doi:10.3760/cma.j.issn.0253-3758.2019.10.003
[12] 晋辉, 郑献召, 沈玲, 等. 三种冠状动脉内灌注用药方案对高血栓负荷急性ST段抬高型心肌梗死患者经皮冠状动脉介入术后心肌灌注及短期预后的影响[J]. 中国心血管杂志, 2024, 29(2): 143-151. doi:10.3969/j.issn.1007-5410. 2024. 02.009 .
[13] LYU W Y, QIN C Y, WANG X T, et al. The application of myocardial contrast echocardiography in assessing microcirculation perfusion in patients with acute myocardial infarction after PCI[J]. BMC Cardiovasc Disord, 2022, 22(1): 233. doi:10.1186/s12872-021-02404-9 .
[14] LAHTI R, RANKINEN J, LYYTIK?INEN L P, et al. High-risk ECG patterns in ST elevation myocardial infarction for mortality prediction[J]. J Electrocardiol, 2022, 74: 13-19. doi:10.1016/j.jelectrocard.2022.07.068 .
[15] SEDOVA K A, DEMIDOVA M M, AZAROV J E, et al. Terminal T-wave inversion predicts reperfusion tachyarrhythmias in STEMI[J]. J Electrocardiol, 2022, 71: 28-31. doi:10.1016/j.jelectrocard.2021.12.008 .
[16] RALAPANAWA U, SIVAKANESAN R, TENNAKOON S, et al. Ischemia-modified albumin: Is it a promising marker in acute coronary syndrome?[J]. BMC Cardiovasc Disord, 2024, 24(1): 436. doi:10.1186/s12872-024-04108-2 .
[17] JAWADE P, KHILLARE K M, MANGUDKAR S, et al. A comparative study of ischemia-modified albumin: A promising biomarker for early detection of acute coronary syndrome (ACS)[J]. Cureus, 2023, 15(8): e44357. doi:10.7759/cureus.44357 .
[18] ALADA? N, ASO?LU R, OZDEMIR M, et al. Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI)[J]. J Med Biochem, 2021, 40(3): 286-294. doi:10.5937/jomb0-28879 .
[19] OHNEWEIN B, SHOMANOVA Z, JIRAK P, et al. Dynamics of the novel cardiac biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF patients undergoing heart failure therapy, a pilot study[J]. J Clin Med, 2025, 14(16): 5668. doi:10.3390/jcm14165668 .
[20] HUANG S, YU L J, SUN G F, et al. Short-term predictive value of sST2 in patients with STEMI following primary PCI: A prospective observational study[J]. BMC Cardiovasc Disord, 2025, 25(1): 21. doi:10.1186/s12872-025-04488-z .
[21] PANTERIS E, DEDA O, PAPAZOGLOU A S, et al. Machine learning algorithm to predict obstructive coronary artery disease: Insights from the CorLipid trial[J]. Metabolites, 2022, 12(9): 816. doi:10.3390/metabo12090816 .
[22] JIN Z L, HE T, PENG L, et al. Lipoprotein(a) and benefit of PCSK9 inhibition in emergency complex higher-risk and indicated patients[J]. Curr Med Sci, 2023, 43(6): 1206-1212. doi:10.1007/s11596-023-2791-9 .
[23] HASSANPOUR M, RAHBARGHAZI R, REZABAKHSH A, et al. Relationship between angiogenesis biomarker endocan and apolipoproteins in patients with acute myocardial infarction[J]. Future Cardiol, 2024, 20(10): 555-561. doi:10.1080/14796678.2024.2365552 .
[24] 谢伟, 苏振琪. 血脂变异性对急性ST段抬高型心肌梗死急诊经皮冠脉介入术后不良心血管事件的预测价值[J]. 实用医学杂志, 2024, 40(15): 2121-2125. doi:10.3969/j.issn.1006-5725.2024.15.013 .
[25] 贺威, 李馨, 王秋雨, 等. 老年急性ST段抬高型心肌梗死患者急诊介入术后慢血流或无复流危险因素及预后分析[J]. 中华老年心脑血管病杂志, 2024, 26(7): 742-745. doi:10.3969/j.issn.1009-0126.2024.07.004 .
[26] WU H L, HURILE B, LI Z P, et al. The predictive value of geriatric nutritional risk index combined with the GRACE score in predicting the risk of one year poor prognosis in elderly patients with non-ST segment elevation myocardial infarction after PCI[J]. Clin Interv Aging, 2024, 19: 705-714. doi:10.2147/CIA.S457971 .
文章导航

/